ReviewFrontiers in pharmacology2026
Non-small cell lung cancer after EGFR-TKI resistance: from drug resistance mechanisms to precision interventions.
Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it